Chemical Structure : Secukinumab
CAS No.: 875356-43-7
货号: PC-Ab1019Not For Human Use, Lab Use Only.
Secukinumab (Cosentyx) is a human monoclonal antibody designed for the treatment of uveitis, rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Secukinumab is an interleukin-17A (IL-17A) inhibitor By targeting IL-17A. Secukinumab has shown excellent efficacy in psoriasis by normalizing skin histology..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Secukinumab (Cosentyx) is a human monoclonal antibody designed for the treatment of uveitis, rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Secukinumab is an interleukin-17A (IL-17A) inhibitor By targeting IL-17A. Secukinumab has shown excellent efficacy in psoriasis by normalizing skin histology.
分子量 | ||
分子式 | Human IgG1-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Secukinumab; Cosentyx; interleukin-17A; AIN-457; AIN457; AIN457A; interleukin-17A antibody; interleukin-17 |
1. 1, Hueber W, et al. Gut. 2012 Dec;61(12):1693-700. 2, Dick AD, et al. Ophthalmology. 2013 Apr;120(4):777-87. 3, Kurzeja M, et al. Am J Clin Dermatol. 2011 Apr 1;12(2):113-25. 4, Hueber W, et al. Sci Transl Med. 2010 Oct 6;2(52):52ra72.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright